Mri Interventions (MRIC) 0.6700 $MRIC MRI Interventions,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mri Interventions (MRIC) 0.6700 $MRIC

MRI Interventions, Inc. Announces 2015 Second Quarter Results
GlobeNewswire - Thu Jul 30, 3:05PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced financial results for the second quarter ended June 30, 2015.

MRI Interventions, Inc. Announces Fiscal 2015 Second Quarter Financial Results Conference Call and Webcast
GlobeNewswire - Fri Jul 24, 8:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) invites investors and analysts to participate in management's broadcast review of the Company's 2015 second quarter results.

MRI Interventions ClearPoint(R) Neuro Navigation System Utilized in First Hippocampal Laser Ablation Neurological Procedure at Yale-New Haven Hospital
GlobeNewswire - Mon Jun 08, 7:01AM CDT
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain, today announced the first stereotactic laser ablation of the hippocampus (SLAH) procedure at Yale-New Haven Hospital. By using the ClearPoint Neuro Navigation System and the Monteris NeuroBlate System in an intra-operative MRI suite, the laser fiber trajectory and target identification was highly accurate, and visible under real time MRI guidance.

MRI Interventions' (MRIC) CEO Frank Grillo on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri May 01, 7:04AM CDT


MRI Interventions Reports 2015 First Quarter Financial Results
GlobeNewswire - Thu Apr 30, 3:00PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today its financial results for the first quarter ended March 31, 2015.

MRI Interventions to Report First Quarter 2015 Financial Results
GlobeNewswire - Thu Apr 23, 7:32AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it will release its first quarter 2015 financial results on Thursday, April 30, 2015, after the close of the U.S. financial markets. MRI Interventions will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the company's results.

Leading neurosurgeons speaking on clinical utility of real-time navigated laser therapy for lesion ablation within Intraoperative MRI Suites at AANS
PR Newswire - Wed Apr 15, 7:25AM CDT
IMRIS, Monteris & MRI Interventions sponsoring luncheon seminar
IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)

MRI Interventions to Exhibit Its ClearPoint Navigation Platform for Neurosurgery at AANS 2015 Annual Meeting
GlobeNewswire - Tue Apr 14, 7:32AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint neuro navigation platform will be on exhibit at the 2015 Annual Meeting of the American Association of Neurological Surgeons (AANS) May 4-6, 2015, in Washington, D.C. Conference attendees are invited to visit the MRI Interventions booth (#708) to learn about the ClearPoint system's unique capability to enable a wide range of neurosurgical procedures under real-time MRI guidance.

Penny Stocks Movers for Medican Enterprises, Advanced Medical Isotope, Radiant Creations Group, CIG Wireless, MRI Interventions, and NuGene
PR Newswire - Wed Mar 25, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Medican Enterprises (OTCMKTS:MDCN), Advanced Medical Isotope (OTCMKTS:ADMD), Radiant Creations Group (OTCBB:RCGP), CIG Wireless (OTCBB:CIGW), MRI Interventions (OTCBB:MRIC), and NuGene (OTCBB:NUGN).

New finance chief at MRI Interventions
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 8:28AM CDT


MRI Interventions' New Chief Financial Officer Harold A. Hurwitz Brings Considerable Medical Device Finance Experience to Growing Company
GlobeNewswire - Tue Mar 17, 7:32AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) is pleased to announce that seasoned medical device financial executive Harold A. (Hal) Hurwitz has been appointed the company's next Chief Financial Officer. Mr. Hurwitz will join the company on March 30, 2015 initially as Vice President, Finance, and he will then assume the CFO position following the filing of the company's quarterly report on Form 10-Q for the first quarter of 2015.
MDT: 69.90 (-0.11)

MRI Interventions' ClearPoint Neuro Navigation System Enables First Brain Biopsy in New GE Intraoperative MRI Scanner at Ohio State University James Cancer Hospital
GlobeNewswire - Tue Mar 10, 7:04AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that a team led by Dr. Brad Elder, Associate Professor, Neurological Surgery at the Ohio State University (OSU) Wexner Medical Center, has utilized the company's ClearPoint(R) neuro navigation system to enable the first brain biopsy within the OSU Arthur G. James Cancer Hospital's new GE 3-T intraoperative magnetic resonance imaging (MRI) scanner.

MRI Interventions' (MRIC) CEO on Frank Grillo Q4 2014 Results -- Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Mar 05, 8:10PM CST


MRI Interventions Announces $10.2 Million Private Placement
GlobeNewswire - Fri Dec 19, 7:30AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced it has entered into a definitive securities purchase agreement with a group of investors for the private placement of approximately 15.8 million shares of its common stock and warrants to purchase approximately 6.3 million shares of its common stock.

MRI Interventions Welcomes Seasoned Medical Device Executive Wendelin Maners as Its New Vice President, Marketing
GlobeNewswire - Thu Dec 04, 7:33AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announces the addition of medical device veteran Wendelin Maners in the role of Vice President, Marketing, as CEO-elect Frank Grillo solidifies his management team. As Vice President, Marketing, Ms. Maners will head all marketing activities and programs, as well as develop and lead internal and external training programs for the Company.
BSX: 16.89 (+0.11), CYBX: 67.00 (+1.08)

MRI Interventions' (MRIC) CEO Kimble Jenkins on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 6:23PM CST


MRI Interventions Announces Third Quarter 2014 Financial Results
GlobeNewswire - Thu Nov 13, 3:00PM CST
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the quarter ended September 30, 2014.

MRI Interventions to Report Third Quarter 2014 Financial Results
GlobeNewswire - Thu Nov 06, 4:16PM CST
MRI Interventions, Inc. (OTCQB: MRIC) announced today that it will release its third quarter 2014 financial results on Thursday, November 13, 2014, after the close of the U.S. financial markets. MRI Interventions will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the company's results.

MRI Interventions Announces Participation in Fall Medical Conferences
GlobeNewswire - Wed Oct 08, 7:35AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced its participation as an exhibitor at two major medical conferences this Fall.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 401

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 239

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 659

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 157

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 508

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 499

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 281

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 440

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 253

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 282

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading

Top 5 Most Recently Viewed Articles

Antengene's XPOVIO® Gains Approval in Thailand for Cancer Treatment

Updated Category News Views 114

Antengene's Recent Approval of XPOVIO® in Thailand Antengene Corporation Limited, a distinguished global biopharmaceutical company, has reached a notable achievement with the approval of XPOVIO® (selinexor) by the Thailand Food and Drug Administration. This approval marks XPOVIO® as the first and only XPO1 inhibitor authorized for sale in the Thai market. The drug,...

Continue Reading
Monumental Pediatric Surgery Advances at Nicklaus Children

Updated Category News Views 23

Redefining Pediatric Surgery with Mixed Reality Cue the drumroll, because Nicklaus Children's Hospital in Miami just pulled off a doozy in the medical field. The region's first pediatric total hip replacement using mixed reality-assisted guidance has taken place, and the ripples from this bad boy could be significant. The Hero of the Hour: Dr. Thomas J. Utset-Ward Dr....

Continue Reading
Contrasting Luxury Real Estate Trends in the U.S. Market

Updated Category News Views 151

The Evolving Landscape of U.S. Luxury Real Estate In the world of luxury real estate, change is the only constant. A recent report sheds light on how the U.S. luxury housing market is adapting to buyer preferences, with 2026 marking an interesting phase in pricing stabilization. Nationally, entry-level luxury prices stand steady at $1.19 million, but the interpretation of...

Continue Reading
Bureau Veritas Explores Potential Merger with SGS

Updated Category News Views 325

Exploring Business Synergies: Bureau Veritas and SGS Recent media discussions have shed light on the evolving landscape of Bureau Veritas as it engages in talks with SGS about the possibility of a business merger. This potential union reflects the growing trend within industries to enhance competencies and create greater value through collaboration. Bureau Veritas, a...

Continue Reading
Equifax Engages Investors in September Conferences Overview

Updated Category News Views 133

Equifax Invites Investors to Upcoming Conferences Equifax®, a leading data, analytics, and technology company recognized by its stock symbol EFX on the NYSE, is gearing up to engage with investors through several key conferences this September. This month presents an excellent opportunity for investors to gain insights into the company's strategy and future direction....

Continue Reading